We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+50.65%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$5.42B
AUM Growth
+$1.85B
(+52%)
Cap. Flow
+$509M
Cap. Flow
% of AUM
9.4%
Top 10 Holdings %
Top 10 Hldgs %
46.89%
Holding
89
New
20
Increased
11
Reduced
36
Closed
9
Top Buys
| 1 |
ADC Therapeutics
ADCT
|
+$210M |
| 2 |
BioNTech
BNTX
|
+$145M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$102M |
| 4 |
Pliant Therapeutics
PLRX
|
+$90.5M |
| 5 |
RPTX
Repare Therapeutics
RPTX
|
+$76.6M |
Top Sells
| 1 |
Biogen
BIIB
|
+$128M |
| 2 |
uniQure
QURE
|
+$90.1M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$75.7M |
| 4 |
Tandem Diabetes Care
TNDM
|
+$56.7M |
| 5 |
Centene
CNC
|
+$49M |
Sector Composition
| 1 | Healthcare | 93.05% |
| 2 | Industrials | 1.02% |
| 3 | Financials | 0.23% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$336M
| $433M | 8% |
12,629,737
+1,412,928
| +13% | +$42.1M |
|
|
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
| $376M | 6.94% |
24,944,695
-236,805
| -0.9% | -$2.89M |
|
|
DCPH
3
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $297M | 5.49% |
4,978,941
-137,322
| -3% | -$7.35M |
|
|
4
ADC Therapeutics
ADCT
$156M
| $259M | 4.78% |
+5,525,870
| New | +$210M |
|
5
argenx
ARGX
$54.1B
| $233M | 4.3% |
1,034,868
-47,202
| -4% | -$8.38M |
|
|
IGMS
6
DELISTED
IGM Biosciences
IGMS
| $230M | 4.24% |
3,144,000
| – | – |
|
|
7
BioNTech
BNTX
$22.8B
| $205M | 3.78% |
3,069,164
+2,898,964
| +1,703% | +$145M |
|
|
ALLK
8
DELISTED
Allakos
ALLK
| $188M | 3.47% |
2,619,080
-357,848
| -12% | -$24M |
|
|
PRNB
9
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $162M | 2.99% |
2,712,388
+451,300
| +20% | +$27.9M |
|
|
MNTA
10
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $157M | 2.89% |
4,705,308
-469,700
| -9% | -$15M |
|
|
EPZM
11
DELISTED
Epizyme, Inc
EPZM
| $136M | 2.52% |
8,485,605
-282,870
| -3% | -$4.94M |
|
|
IMMU
12
DELISTED
Immunomedics Inc
IMMU
| $124M | 2.28% |
+3,489,900
| New | +$102M |
|
|
13
Pliant Therapeutics
PLRX
$68.7M
| $111M | 2.04% |
+3,410,657
| New | +$90.5M |
|
|
ONEM
14
DELISTED
1Life Healthcare
ONEM
| $109M | 2.02% |
3,010,684
-112,700
| -4% | -$3.17M |
|
15
Atara Biotherapeutics
ATRA
$76.6M
| $99.7M | 1.84% |
273,735
+62,000
| +29% | +$15.7M |
|
16
Beam Therapeutics
BEAM
$3.12B
| $94M | 1.74% |
3,356,958
-2,300
| -0.1% | -$49.6K |
|
17
Cigna
CI
$79.8B
| $91.2M | 1.68% |
486,100
+185,500
| +62% | +$35.2M |
|
18
Aprea Therapeutics
APRE
$8.82M
| $88M | 1.62% |
113,436
| – | – |
|
19
Regenxbio
RGNX
$621M
| $82.4M | 1.52% |
2,236,766
-101,700
| -4% | -$3.79M |
|
20
Zentalis Pharmaceuticals
ZNTL
$327M
| $79.8M | 1.47% |
+1,661,205
| New | +$63.7M |
|
21
Replimune Group
REPL
$824M
| $77.1M | 1.42% |
3,104,193
+123,700
| +4% | +$2.19M |
|
|
RPTX
22
DELISTED
Repare Therapeutics
RPTX
| $74M | 1.37% |
+2,386,174
| New | +$76.6M |
|
|
GNMK
23
DELISTED
GenMark Diagnostics, Inc
GNMK
| $72.1M | 1.33% |
+4,903,400
| New | +$49.8M |
|
24
Neurogene
NGNE
$779M
| $67.1M | 1.24% |
202,061
| – | – |
|
|
HRC
25
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $64.2M | 1.19% |
+585,000
| New | +$61.3M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO